Latest / The Biorevolution Podcast
AI in drug development – Expanding the option space
The biorevolution podcast #27
In the expensive and failure-prone process of drug development, artificial intelligence (AI) can serve both as an efficiency tool and as a creativity tool. Increased efficiency means shorter timelines, reduced investment, and earlier insights into success or failure. This can lead to more opportunities to bring new drugs to patients. Increased creativity means exploring new areas in drug discovery and development, such as identifying new patterns in targets, drug molecules, and patient populations that may be unintelligible to the human eye. While we are…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.